Abivax Sa ADR
(ABVX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 06-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 689,304 | 69,186 | 109,117 | 156,062 | 239,413 |
| Marketable Securities | 10,720 | 9,102 | 7,931 | 8,174 | 147 |
| Receivables | 23,870 | 19,455 | 22,717 | 20,447 | 22,111 |
| TOTAL | $723,894 | $97,743 | $139,765 | $184,683 | $261,671 |
| Non-Current Assets | |||||
| PPE Net | 2,237 | 2,451 | 2,539 | 4,360 | 2,772 |
| Investments And Advances | 5,964 | 6,302 | 6,299 | 6,405 | 13,766 |
| Intangibles | 29,252 | 28,408 | 26,364 | 0 | 26,951 |
| Other Non-Current Assets | 838 | 913 | 904 | 28,106 | 1,211 |
| TOTAL | $38,291 | $38,074 | $36,106 | $38,871 | $44,699 |
| Total Assets | $762,184 | $135,817 | $175,870 | $222,077 | $306,369 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 34,366 | 55,448 | 46,738 | 47,362 | 38,366 |
| Accounts payable and accrued liabilities | 35,089 | 65,271 | 59,549 | 47,422 | 34,238 |
| Accrued Expenses | 9,271 | 3,664 | 3,229 | 5,096 | 6,405 |
| Other current liabilities | 13,340 | 3,159 | 1,882 | 1,837 | 7,109 |
| TOTAL | $92,064 | $127,542 | $111,398 | $101,716 | $86,117 |
| Non-Current Liabilities | |||||
| Long Term Debt | 14,483 | 20,316 | 25,677 | 31,442 | 41,599 |
| Other Non-Current Liabilities | 58,052 | 42,766 | 45,740 | 45,003 | 42,458 |
| TOTAL | $72,535 | $63,082 | $71,417 | $76,445 | $84,056 |
| Total Liabilities | $164,598 | $190,625 | $182,815 | $178,161 | $170,174 |
| Shareholders' Equity | |||||
| Common Shares | 909 | 721 | 668 | 685 | 677 |
| Retained earnings | -782,942 | -600,070 | -512,546 | -474,911 | -380,255 |
| Other shareholders' equity | 869 | 549 | 144 | -81 | 36 |
| TOTAL | $597,586 | $-54,808 | $-6,945 | $43,916 | $136,196 |
| Total Liabilities And Equity | $762,184 | $135,818 | $175,870 | $222,077 | $306,369 |